Nature Communications (Dec 2022)

A pH-responsive T1-T2 dual-modal MRI contrast agent for cancer imaging

  • Hongwei Lu,
  • An Chen,
  • Xindan Zhang,
  • Zixiang Wei,
  • Rong Cao,
  • Yi Zhu,
  • Jingxiong Lu,
  • Zhongling Wang,
  • Leilei Tian

DOI
https://doi.org/10.1038/s41467-022-35655-x
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 12

Abstract

Read online

Magnetic resonance imaging (MRI) is a well-established non-invasive medical imaging technology. Here, to improve the performance of the technique, the authors describe the design of a pH-responsive T1-T2 dual-modal MRI contrast agent, showing enhanced imaging sensitivity in preclinical cancer models.